1. A new triphenylethylene compound, Fc-1157a

   • Sinikka Kallio
   • Lauri Kangas
   • Reijo Toivola

   Original Articles Pages: 103 - 108

2. A new triphenylethylene compound, Fc-1157a

   • Lauri Kangas
   • Anna-Liisa Nieminen
   • Reijo Toivola

   Original Articles Pages: 109 - 113

3. Enhanced therapeutic effect of methotrexate in experimental rat leukemia after inactivation of cobalamin (vitamin B12) by nitrous oxide

   • A. C. M. Kroes
   • J. Lindemans
   • J. Abels

   Original Articles Pages: 114 - 120

4. Distribution and tumor penetration properties of a radiosensitizer 2-[¹⁴C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography

   • G. Akel
   • P. Benard
   • G. Soula

   Original Articles Pages: 121 - 126

5. Loss of viability and induction of DNA damage in human leukemic myeloblasts and lymphocytes by m-AMSA

   • L. W. Brox
   • A. Belch
   • E. Pollock

   Original Articles Pages: 127 - 132

6. Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats

   • A. Lázníčková
   • M. Lázníček
   • J. Drobník

   Original Articles Pages: 133 - 136

7. Therapeutic response to taxol of six human tumors xenografted into nude mice

   • J. Riondel
   • M. Jacrot
   • P. Potier

   Original Articles Pages: 137 - 142

8. Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)

   • Katherine Lu
   • Niramol Savaraj
   • Ti Li Loo

   Original Articles Pages: 143 - 148

9. The clinical pharmacology of mitozantrone

   • John F. Smyth
   • Janet S. Macpherson
   • C. Roland Wolf

   Original Articles Pages: 149 - 152

10. Serum and tissue concentrations of doxorubicin after IV administration of doxorubicin or doxorubicin-DNA complex to patients with gastrointestinal cancer

    • Peter Gunvén
    • Nils Olof Theve
    • Curt Peterson

    Original Articles Pages: 153 - 156

11. Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: A randomised, controlled trial

    • Michael Cullen
    • David Morgan
    • Midlands Small Cell Lung Cancer Group

    Original Articles Pages: 157 - 160

12. Treatment of leukemia and myelodysplastic syndromes with orally administered N⁴-palmitoyl-l-β-D-arabinofuranosylcytosine

    • Ryuzo Ohno
    • Masami Hirano
    • Tokai Blood Cancer Study Group

    Original Articles Pages: 161 - 164

13. Adverse effect of cis-diamminedichloroplatinum II (CDDP) on porphyrin metabolism in man

    • C. G. Alexopoulos
    • G. Chalevelakis
    • G. Pallikaris

    Original Articles Pages: 165 - 170

14. Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine

    • P. Bore
    • N. Lena
    • Y. Carcassonne

    Original Articles Pages: 171 - 176

15. The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer

    • P. E. Lønning
    • P. M. Ueland
    • S. Kvinnsland

    Original Articles Pages: 177 - 181

16. Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy

    • P. K. Buamah
    • C. Cornell
    • A. L. Harris

    Original Articles Pages: 182 - 184

17. Renal function in the elimination of oral melphalan in patients with multiple myeloma

    • C. G. Adair
    • J. M. Bridges
    • Z. R. Desai

    Original Articles Pages: 185 - 188

18. Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone

    • Zalmen A. Arlin
    • Ellin Berman
    • Gary Dukart

    Original Articles Pages: 189 - 190

19. Acute and long-term nephrotoxicity of cis-platinum in man

    • Steffen Groth
    • H. Nielsen
    • M. Rørth

    Original Articles Pages: 191 - 196

20. Second Annual Symposium O.O.M.E.R.

    Meeting Announcements Pages: A3 - A3